factMR-logo.png
Polycystic Ovary Syndrome Treatment Market to Reach $6.84 Billion by 2034 with 4.7% CAGR | Fact.MR Report
November 26, 2024 07:30 ET | FACT.MR
Rockville, MD, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Polycystic ovarian syndrome is a disorder in which several tiny cysts (fluid-filled sacs) grow in the ovaries. The market is projected to expand...
Magstim Inspire TMS system photo
FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression
November 12, 2024 08:11 ET | Magstim EGI
FDA clears Magstim INSPIRE Transcranial Magnetic Stimulation TMS system to treat patients with Depression, OCD, Anxious Depression
logo 600X600.png
Narcolepsy Market to Reach US$ 4.68 Billion by 2031, Rising at a CAGR of 9.3%, Report by CoherentMI
October 15, 2024 06:55 ET | CMI
Burlingame, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, Narcolepsy Market is estimated to value at US$ 2.53 Billion in the year 2024, and is anticipated to reach US$...
Research Nester Logo.jpg
Fibromyalgia Treatment Market revenue to cross USD 536 Million by 2033, says Research Nester
February 06, 2024 07:00 ET | Research Nester
New York , Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market size is projected to grow at a CAGR of over 9% from 2023 to 2033. The market is expected to garner a revenue of...
SNS-INSIDER-300X300.jpg
Antidepressants Market to Surpass USD 23.22 Billion by 2030 Driven by Rising Mental Health Awareness and Stigma Reduction | Exclusive Research by SNS Insider
August 14, 2023 09:10 ET | SNS Insider pvt ltd
Pune, Aug. 14, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that the Antidepressants Market reached a value of USD 15.6 billion in 2022. It is projected to reach USD 23.22 billion by...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Schizophrenia Drugs Market Size to Witness Healthy Valuation of US$ 12.6 Billion at 5.6% CAGR by 2032 | Market.us Report
May 25, 2023 07:54 ET | Market.Us
New York, May 25, 2023 (GLOBE NEWSWIRE) -- As per this latest study by Market.us, The global Schizophrenia Drugs Market was valued at US$ 7.4 Bn in 2022. It is projected to expand at a CAGR of 5.6%...
logo 600X600.png
Global Post-traumatic Stress Disorder Market to Surpass US$ 1536.8 Million by 2030, Says Coherent Market Insights (CMI)
February 15, 2023 09:30 ET | CMI
Burlingame, Feb. 15, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global post-traumatic stress disorder market is estimated to be valued at US$ 1034.3 million in 2022 and is...
logo 600X600.png
Global Pain Management Drugs Market to Surpass US$ 105,252.1 Million by 2030, Says Coherent Market Insights (CMI)
July 27, 2022 09:10 ET | CMI
Seattle, July 27, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global pain management drugs market is estimated to be valued at US$ 76,415.7 million in 2022 and is expected to...
Research Nester  Logo
Global Quadriplegia Treatment Market to Grow with a CAGR of ~4% During 2022-2031; Market to Grow on Account of the Increasing Cases of Spinal Cord Injuries and Growing Numbers of Road Accidents
June 22, 2022 06:30 ET | Research Nester
New York, June 22, 2022 (GLOBE NEWSWIRE) -- As sourced by a report by the World Health Organization (WHO), every year, between 250,000 to 500,000 people suffer a spinal cord injury in the world...
TIP_link_300x300.jpg
CIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion, Globally, by 2028: The Insight Partners
May 26, 2022 15:07 ET | The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Chemotherapy-Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global...